BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16648423)

  • 1. Cervical cancer.
    Moore DH
    Obstet Gynecol; 2006 May; 107(5):1152-61. PubMed ID: 16648423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of early and locally advanced cervical cancer.
    Barbera L; Thomas G
    Semin Oncol; 2009 Apr; 36(2):155-69. PubMed ID: 19332250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.
    Monk BJ; Tewari KS; Koh WJ
    J Clin Oncol; 2007 Jul; 25(20):2952-65. PubMed ID: 17617527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer.
    Orr JW
    Surg Oncol Clin N Am; 1998 Apr; 7(2):299-316. PubMed ID: 9537978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of endometrial and cervical cancer.
    Sahdev A; Reznek RH
    Ann N Y Acad Sci; 2008 Sep; 1138():214-32. PubMed ID: 18837902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is systematic scalene node biopsy in pretreatment evaluation of locally advanced cervical carcinoma necessary? Systematic dissection and histopathology of left scalene node biopsies in patients with locally advanced cervical carcinoma.
    Samouëlian V; Baranzelli MC; Narducci F; Taïeb S; Cabaret V; Querleu D; Leblanc E
    Gynecol Oncol; 2006 Dec; 103(3):1091-4. PubMed ID: 16890275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer.
    Benedetti Panici P; Bellati F; Manci N; Pernice M; Plotti F; Di Donato V; Calcagno M; Zullo MA; Muzii L; Angioli R
    Ann Surg Oncol; 2007 Sep; 14(9):2643-8. PubMed ID: 17562114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183.
    Amendola MA; Hricak H; Mitchell DG; Snyder B; Chi DS; Long HJ; Fiorica JV; Gatsonis C
    J Clin Oncol; 2005 Oct; 23(30):7454-9. PubMed ID: 16234512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
    Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
    J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
    Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
    Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of pregnant women with advanced cervical cancer].
    Vincens C; Dupaigne D; de Tayrac R; Mares P
    Gynecol Obstet Fertil; 2008 Apr; 36(4):365-72. PubMed ID: 18378182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V; Cormio G; Vicino M; Selvaggi L
    Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for recurrent cervical cancer.
    Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early invasive disease: risk assessment and management.
    Thomas GM; Stehman FB
    Semin Oncol; 1994 Feb; 21(1):17-24. PubMed ID: 8310304
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer.
    Mandic A; Novakovic P; Mihajlovic O; Stojiljkovic B; Rajovic J; Davidovic M
    J BUON; 2008; 13(1):51-4. PubMed ID: 18404786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer therapy: current, future and anti-angiogensis targeted treatment.
    Willmott LJ; Monk BJ
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):895-903. PubMed ID: 19589029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wertheim-Meigs radical hysterectomy for cervical cancer stage IIB].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(2):22-4. PubMed ID: 17469447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controversies on the staging of microinvasive cervix carcinoma].
    Di Leo S; Caragliano L; Cassaro N; Meli MT; Consalvo P; Caschetto S
    Minerva Ginecol; 2000 Sep; 52(9):345-9. PubMed ID: 11189964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node assessment in cervical cancer: prognostic and therapeutic implications.
    Gien LT; Covens A
    J Surg Oncol; 2009 Mar; 99(4):242-7. PubMed ID: 19048600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.